Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemia.

Bidet A, Dulucq S, Smol T, Marceau-Renaut A, Morisset S, Coiteux V, Noël-Walter MP, Nicolini FE, Tigaud I, Luquet I, Struski S, Gaillard B, Penther D, Tondeur S, Nadal N, Hermet E, Véronèse L, Réa D, Gervais C, Theisen O, Terré C, Cony-Makhoul P, Lefebvre C, Gaillard JB, Radford I, Vervaeke AL, Barin C, Chapiro E, Nguyen-Khac F, Etienne G, Preudhomme C, Mahon FX, Roche-Lestienne C; Groupe Francophone de Cytogénétique Hématologique (GFCH) and the French Intergroup of Chronic Myeloid Leukemia (Fi-LMC).

Haematologica. 2019 Jun;104(6):1150-1155. doi: 10.3324/haematol.2018.208801. Epub 2018 Dec 20.

2.

[Prognosis of clonal chromosomal abnormalities in Philadelphia negative metaphases cells in chronic myeloid leukemia with tyrosine kinase inhibitor therapy].

Zhao HF, Zhang Y, Hu JY, Li Z, Zhou J, Yu FK, Zu YL, Zhou H, Wei XD, Song YP.

Zhonghua Xue Ye Xue Za Zhi. 2019 Mar 14;40(3):209-214. doi: 10.3760/cma.j.issn.0253-2727.2019.03.009. Chinese.

PMID:
30929388
3.

Occurrence of chromosomal abnormalities in Philadelphia chromosome-negative metaphases in patients with chronic-phase chronic myeloid leukemia undergoing TKI treatments.

Sheng G, Xue M, Wang Q, Wen L, Chen S, Zhang X, Yang X.

Leuk Lymphoma. 2019 Jul 8:1-9. doi: 10.1080/10428194.2019.1636984. [Epub ahead of print]

PMID:
31282805
4.

Factors influencing a second myeloid malignancy in patients with Philadelphia-negative -7 or del(7q) clones during tyrosine kinase inhibitor therapy for chronic myeloid leukemia.

Groves MJ, Sales M, Baker L, Griffiths M, Pratt N, Tauro S.

Cancer Genet. 2011 Jan;204(1):39-44. doi: 10.1016/j.cancergencyto.2010.08.017.

PMID:
21356190
5.

The prognostic impact of loss of chromosome 7 material detected by fluorescence in situ hybridization (FISH) in myeloid malignancies.

El-Menoufy MAM, Mourad ZI, Farahat NM.

J Egypt Natl Canc Inst. 2018 Dec;30(4):133-138. doi: 10.1016/j.jnci.2018.11.001. Epub 2018 Nov 22.

6.

The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells.

Deininger MW, Cortes J, Paquette R, Park B, Hochhaus A, Baccarani M, Stone R, Fischer T, Kantarjian H, Niederwieser D, Gambacorti-Passerini C, So C, Gathmann I, Goldman JM, Smith D, Druker BJ, Guilhot F.

Cancer. 2007 Oct 1;110(7):1509-19.

7.

Secondary Philadelphia chromosome acquired during therapy of acute leukemia and myelodysplastic syndrome.

Kurt H, Zheng L, Kantarjian HM, Tang G, Ravandi-Kashani F, Garcia-Manero G, Gong Z, Amin HM, Konoplev SN, Routbort MJ, Han X, Wang W, Medeiros LJ, Hu S.

Mod Pathol. 2018 Jul;31(7):1141-1154. doi: 10.1038/s41379-018-0014-x. Epub 2018 Feb 14.

8.

Clonal chromosomal aberrations in Philadelphia negative cells such as monosomy 7 and trisomy 8 may persist for years with no impact on the long term outcome in patients with chronic myeloid leukemia.

Wasilewska EM, Panasiuk B, Gniot M, Sawicka A, Kozłowska K, Lewandowski K, Kłoczko J, Midro AT.

Cancer Genet. 2017 Oct;216-217:1-9. doi: 10.1016/j.cancergen.2017.04.066. Epub 2017 Apr 28.

PMID:
29025581
9.

Survival outcomes for clonal evolution in chronic myeloid leukemia patients on second generation tyrosine kinase inhibitor therapy.

Verma D, Kantarjian H, Shan J, O'Brien S, Estrov Z, Garcia-Manero G, Koller C, Borthakur G, Cortes J.

Cancer. 2010 Jun 1;116(11):2673-81. doi: 10.1002/cncr.25015.

10.

Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities.

Möllgård L, Saft L, Treppendahl MB, Dybedal I, Nørgaard JM, Astermark J, Ejerblad E, Garelius H, Dufva IH, Jansson M, Jädersten M, Kjeldsen L, Linder O, Nilsson L, Vestergaard H, Porwit A, Grønbæk K, Hellström-Lindberg E.

Haematologica. 2011 Jul;96(7):963-71. doi: 10.3324/haematol.2010.039669. Erratum in: Haematologica. 2011 Aug;96(8):1240. Lindberg, Eva Hellström [corrected to Hellström-Lindberg, Eva].

11.

Genomic Copy Number Variations in the Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients with del(5q) and/or -7/del(7q).

Zhang R, Kim YM, Wang X, Li Y, Lu X, Sternenberger AR, Li S, Lee JY.

Int J Med Sci. 2015 Sep 1;12(9):719-26. doi: 10.7150/ijms.12612. eCollection 2015.

12.

3q26.2/EVI1 rearrangement is associated with poor prognosis in classical Philadelphia chromosome-negative myeloproliferative neoplasms.

Hu Z, Medeiros LJ, Wang W, Chen Z, Tang G, Hodjat P, Yang S, Fang L, Li Y, Verstovsek S, Hu S.

Mod Pathol. 2017 Jul;30(7):940-951. doi: 10.1038/modpathol.2017.19. Epub 2017 Mar 24.

13.

How I investigate Clonal cytogenetic abnormalities of undetermined significance.

Tang G, Medeiros LJ, Wang SA.

Int J Lab Hematol. 2018 Aug;40(4):385-391. doi: 10.1111/ijlh.12826. Epub 2018 Apr 6. Review.

PMID:
29624895
14.
15.

Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemia.

Kim TD, Türkmen S, Schwarz M, Koca G, Nogai H, Bommer C, Dörken B, Daniel P, le Coutre P.

Haematologica. 2010 Apr;95(4):582-8. doi: 10.3324/haematol.2009.014712. Epub 2009 Dec 16.

16.

[Cytogenetic and clinical analysis of -7/7q- abnormalities in acute leukemia and myelodysplastic syndrome].

Meng HT, Mai WY, Chen ZM, Lou JY, Jin J.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Aug;12(4):460-3. Chinese.

PMID:
15363131
17.

Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome.

Cordoba I, González-Porras JR, Nomdedeu B, Luño E, de Paz R, Such E, Tormo M, Vallespi T, Collado R, Xicoy B, Andreu R, Muñoz JA, Solé F, Cervera J, del Cañizo C; Spanish Myelodysplastic Syndrome Registry.

Cancer. 2012 Jan 1;118(1):127-33. doi: 10.1002/cncr.26279. Epub 2011 Jun 29.

18.

Serial cytogenetic studies in allografted patients with chronic myeloid leukemia.

Bilhou-Nabera C, Bernard P, Marit G, Viard F, Gharbi MJ, Wen Z, Lacombe F, Broustet A, Reiffers J.

Bone Marrow Transplant. 1992 Apr;9(4):263-8.

PMID:
1600414
19.
20.

Significance of cytogenetic clonal evolution in chronic myelogenous leukemia.

Majlis A, Smith TL, Talpaz M, O'Brien S, Rios MB, Kantarjian HM.

J Clin Oncol. 1996 Jan;14(1):196-203.

PMID:
8558198

Supplemental Content

Support Center